
Duc T. Duong
Examiner (ID: 7909, Phone: (571)272-3122 , Office: P/2467 )
| Most Active Art Unit | 2467 |
| Art Unit(s) | 2663, 2467, 2419, 2619, 2616 |
| Total Applications | 1201 |
| Issued Applications | 977 |
| Pending Applications | 137 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12347166
[patent_doc_number] => 09951225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Rhodamine derivatives dyes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/252597
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13120
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/252597 | Rhodamine derivatives dyes and uses thereof | Aug 30, 2016 | Issued |
Array
(
[id] => 12347166
[patent_doc_number] => 09951225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Rhodamine derivatives dyes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/252597
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13120
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/252597 | Rhodamine derivatives dyes and uses thereof | Aug 30, 2016 | Issued |
Array
(
[id] => 12347166
[patent_doc_number] => 09951225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Rhodamine derivatives dyes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/252597
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13120
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15252597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/252597 | Rhodamine derivatives dyes and uses thereof | Aug 30, 2016 | Issued |
Array
(
[id] => 11336666
[patent_doc_number] => 20160362422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'BROAD SPECTRUM BETA-LACTAMASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/247536
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15655
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15247536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/247536 | Broad spectrum beta-lactamase inhibitors | Aug 24, 2016 | Issued |
Array
(
[id] => 12105247
[patent_doc_number] => 09861714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Cage amine ligands for metallo-radiopharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 15/240836
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14856
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/240836 | Cage amine ligands for metallo-radiopharmaceuticals | Aug 17, 2016 | Issued |
Array
(
[id] => 11457325
[patent_doc_number] => 20170051231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'Method of Extracting CBD, THC, and other Compounds from Cannabis using Controlled Cavitation'
[patent_app_type] => utility
[patent_app_number] => 15/240450
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2930
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/240450 | Method of extracting CBD, THC, and other compounds from cannabis using controlled cavitation | Aug 17, 2016 | Issued |
Array
(
[id] => 11436044
[patent_doc_number] => 20170037065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'BRANCHED SILOXANES AND METHODS FOR SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 15/232138
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5622
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232138 | Branched siloxanes and methods for synthesis | Aug 8, 2016 | Issued |
Array
(
[id] => 12166078
[patent_doc_number] => 09884838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Stabilized levulinic ester ketals'
[patent_app_type] => utility
[patent_app_number] => 15/223925
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20761
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15223925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/223925 | Stabilized levulinic ester ketals | Jul 28, 2016 | Issued |
Array
(
[id] => 13519335
[patent_doc_number] => 20180311210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METHOD FOR INHIBITING GROWTH OF CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 15/221311
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/221311 | Method for inhibiting growth of cancer cells | Jul 26, 2016 | Issued |
Array
(
[id] => 11581682
[patent_doc_number] => 09636302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Lipids and compositions for intracellular delivery of biologically active compounds'
[patent_app_type] => utility
[patent_app_number] => 15/219602
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 17
[patent_no_of_words] => 16690
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15219602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/219602 | Lipids and compositions for intracellular delivery of biologically active compounds | Jul 25, 2016 | Issued |
Array
(
[id] => 11497712
[patent_doc_number] => 20170071898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/220127
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19610
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/220127 | Ultrapure tetrahydrocannabinol-11-oic acids | Jul 25, 2016 | Issued |
Array
(
[id] => 13314059
[patent_doc_number] => 20180208566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => Deuterated Meclizine
[patent_app_type] => utility
[patent_app_number] => 15/745929
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745929 | Deuterated Meclizine | Jul 20, 2016 | Abandoned |
Array
(
[id] => 13970395
[patent_doc_number] => 10214538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Process for preparation of Darunavir
[patent_app_type] => utility
[patent_app_number] => 15/211525
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7650
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15211525
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/211525 | Process for preparation of Darunavir | Jul 14, 2016 | Issued |
Array
(
[id] => 13137325
[patent_doc_number] => 10085973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity
[patent_app_type] => utility
[patent_app_number] => 15/210554
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 11760
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15210554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/210554 | Pharmaceutical composition containing a compound having a thrombopoietin receptor agonistic activity | Jul 13, 2016 | Issued |
Array
(
[id] => 11121915
[patent_doc_number] => 20160318889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'SECOND-ORDER NONLINEAR OPTICAL COMPOUND AND NONLINEAR OPTICAL ELEMENT COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/208976
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 71200
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208976 | Second-order nonlinear optical compound and nonlinear optical element comprising the same | Jul 12, 2016 | Issued |
Array
(
[id] => 11114835
[patent_doc_number] => 20160311808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'CYCLOPROPANAMINE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/203551
[patent_app_country] => US
[patent_app_date] => 2016-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69717
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/203551 | Cyclopropanamine compound and use thereof | Jul 5, 2016 | Issued |
Array
(
[id] => 11114843
[patent_doc_number] => 20160311814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'CYCLOPROPANAMINE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/203522
[patent_app_country] => US
[patent_app_date] => 2016-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69851
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/203522 | Cyclopropanamine compound and use thereof | Jul 5, 2016 | Issued |
Array
(
[id] => 12037589
[patent_doc_number] => 09815807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Method for producing 2-furaldehyde'
[patent_app_type] => utility
[patent_app_number] => 15/194210
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15114
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15194210
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/194210 | Method for producing 2-furaldehyde | Jun 26, 2016 | Issued |
Array
(
[id] => 14913587
[patent_doc_number] => 10428099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Pharmaceutical co-crystal composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/736179
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 10710
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736179
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736179 | Pharmaceutical co-crystal composition and use thereof | Jun 26, 2016 | Issued |
Array
(
[id] => 14896851
[patent_doc_number] => 20190292191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/314574
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 359
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314574 | Heteroaryl substituted aminopyridine compounds | Jun 22, 2016 | Issued |